ADT Plus Radiotherapy Prolongs Survival in Some Prostate Cancer Patients

Share this content:

Adding androgen deprivation therapy (ADT) to radiation therapy has been shown to improve overall survival for men with intermediate-risk and high-risk prostate cancer. However, hormone therapy may be hazardous for men with pre-existing heart conditions. John Schieszer has the latest on the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters